Market News

Latest news from Stock markets.


...
BTS Group AB (publ) Year end report January – December 2025

2025 a disappointment, expected to go back to earnings growth in the first quarter 2026  October 1 – December 31, 2025 Net sales amounted to MSEK 710 (796). Currency adjusted growth was –1%, where of –5% was organic.

...keep reeding on globenewswire.com

...
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY trial Regimen offers another option for the potential of time off treatment, marking a meaningful advance in long-term disease management NORTH CHICAGO, Ill., Feb. 20, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and acalabrutinib for the treatment of previously untreated adult patients with chronic lymphocytic leukemia (CLL).

...keep reeding on prnewswire.com

...
Tetragon Financial Group Limited Investor Call on 6 March 2026

LONDON, Feb. 20, 2026 /PRNewswire/ -- Tetragon will host a conference call for investors on Friday, 6 March 2026 at 15:00 GMT / 10:00 EST to discuss its annual report and to provide a company update. During the call, Tetragon's investment manager will also seek to address questions raised by investors, including questions e-mailed to ir@tetragoninv.com.

...keep reeding on prnewswire.com

...
Hungary's government to release 250,000 tons of crude oil from strategic reserves

Hungary's government is going to release 250,000 tons of crude oil from its strategic reserves after oil flows stopped on the Druzhba pipeline, the official journal of the government said in a decree published late on Thursday.

...keep reeding on reuters.com

...
Interactive Brokers: The Quiet Compounder Riding The Global Trading Boom

Interactive Brokers remains a buy despite a strong run in the stock that has deposited shares at a 30x+ P/E multiple. IBKR's operating metrics—DARTs, client equity, and accounts—are compounding rapidly, driving record net interest income and pre-tax margins near 80%. Strong client and balance growth have, and should continue to, offset rate sensitivity, supporting robust earnings power and a sustainable double-digit EPS growth outlook.

...keep reeding on seekingalpha.com

...
Oil Hits Six-Month High Amid US-Iran Tensions

Oil rose to a six-month high as escalating tensions in Iran weighed on risk sentiment. The commodity is up more than 6% this week to $72 a barrel after US President Donald Trump said Iran had 15 days at most to reach a deal over its nuclear program.

...keep reeding on youtube.com

...
PRESS RELEASE: NACON announces the temporary suspension of trading in its shares on Euronext Paris

Press Release            Lesquin, 20 February 2026, 7.30 NACON announces the temporary suspension of trading in its shares on Euronext Paris Lesquin, 20 February 2026, Nacon (the “Company”) announces that it has requested Euronext Paris to temporarily suspend trading in its shares on the Euronext Paris regulated (ISIN : FR0013482791) as of market opening today. On 17 February 2026, the Company acknowledges the press release issued on the same date by its majority shareholder, Bigben Interactive (“BBI”), stating that as of today it is unable to proceed with the partial repayment of €43 million to the holders of bonds issued by BBI.

...keep reeding on globenewswire.com

...
BW Offshore: Invitation to Q4 2025 Presentation 27 February

Invitation to Q4 2025 Presentation 27 February BW Offshore will release its Q4 2025 results on Friday 27 February at 07:30 CET. A conference call followed by Q&A will be hosted by CEO Marco Beenen and CFO Ståle Andreassen the same day at 09:00 CET.

...keep reeding on globenewswire.com

...
PRESS RELEASE: BIGBEN announces the temporary suspension of trading in its shares on Euronext Paris and its bonds on Euronext Access Paris

Press Release                                                                 Lesquin, 20 February 2026, 7:30

...keep reeding on globenewswire.com

...
DANONE: 2025: Another year of strong delivery

2025 Full-Year Results Press release – Paris, February 20, 2026 at 7:30am CET 2025: Another year of strong delivery FY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix up +2.7%, and price up +1.8% Q4 sales up +4.7% LFL, driven again by strong volume/mix, up +2.5%, and price up +2.1% Sustained momentum in Europe, driven by continued progress in EDP and solid performance in Adult Medical Nutrition and Waters Soft Q4 performance in North America, despite sustained momentum in High Protein and a solid Specialized Nutrition performance Closing a year of exceptional performance in China, North Asia & Oceania with strong Q4 in Specialized Nutrition and EDP Recurring operating margin up +44 basis points (bps) at 13.4% driven by further improvement in margin from operations while continuing to reinvest into future growth Recurring EPS up +4.6% to €3.80 €2.8bn Free cash flow, reflecting strong operating performance Proposed dividend up +4.7% to €2.25 Recognized global sustainability leadership: CDP ‘Triple A' List and worldwide B Corp certification 2026 guidance in line with mid-term ambition: like-for-like sales growth expected between +3% and +5%, with recurring operating income growing faster than sales Full-Year 2025 Key Figures in millions of euros unless stated otherwise FY 2024 FY 2025 Reported change Like-for-like change (LFL) Sales 27,376 27,283 -0.3% +4.5% Recurring operating income 3,558 3,665 +3.0%   Recurring operating margin 13.0% 13.4% +44 bps   Non-recurring operating income and expenses (179) (725) (546)   Operating income 3,379 2,940 -13.0%   Operating margin 12.3% 10.8% -157 bps   Recurring net income – Group share 2,345 2,461 +5.0%   Non-recurring net income – Group share (324) (636) (313)   Net income – Group share 2,021 1,825 -9.7%   Recurring diluted EPS (€) 3.63 3.80 +4.6%   EPS (€) 3.13 2.82 -10.1%   Cash flow from operating activities 3,831 3,779 -1.3%   Free cash flow 3,003 2,799 -6.8%   1 Antoine de Saint-Affrique: CEO statement In 2025, we again delivered broad ‑ based, quality growth, reaffirming the strength and resilience of our health ‑ focused portfolio. Like ‑ for ‑ like sales grew +4.5%, driven by positive volume/mix and supported by our multi-engine growth model.

...keep reeding on globenewswire.com

...
Air Liquide narrowly beats recurring operating income forecast in 2025

French industrial gases group Air Liquide reported slightly higher than expected recurring operating income for 2025 on Friday, citing efficiencies, pricing management particularly in the Industrial Merchant unit, and dynamic asset portfolio management.

...keep reeding on reuters.com

...
Casual Dining's Awakening: Chili's 8.6% Same-Store Sales Growth Leads the Way

Texas Roadhouse impressed in its most recent quarter, posting 6.1% growth in same-restaurant sales (comps). In December, Darden Restaurants reported a 4.3% rise in comps, driven by strength at its Olive Garden brand.

...keep reeding on fool.com

...
Agentic AI deployment and research constrained by memory chip shortage: Google DeepMind CEO

Demis Hassabis, CEO of Google DeepMind, shares his perspective on China's progress in AI development. He also says that the memory chip shortage has become a bottleneck, physically constraining the research and deployment of AI models.

...keep reeding on youtube.com

...
FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application for giredestrant, an investigational oral therapy, in combination with everolimus for the treatment of adult patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated locally advanced or metastatic breast cancer follow.

...keep reeding on businesswire.com

...
AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript

AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Prosafe SE: Halvdan Kielland appointed as permanent CFO

Oslo, 20 February 2026 - Prosafe SE has appointed Halvdan Kielland as permanent chief financial officer (CFO). Mr. Kielland joined Prosafe as Corporate Finance Lead in January 2025 and was appointed Interim CFO in November 2025.

...keep reeding on globenewswire.com

...
Maverick Receives Drill Permits and Prepares to Drill James Bay Cu-Zn-Au-Ag Nottaway Project

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - CDN Maverick Capital Corp. (CSE: CDN) (OTCQB: AXVEF) (FSE: 338B) ("Maverick" or the "Company") is pleased to announce that it has been granted the Authorization of impact-causing exploration work permit ("ATI") from Québec's Ministère des Ressources Naturelles et des Forêts, authorizing diamond drilling on the Company's 100%-owned Nottaway Property, located approximately 75 km north-northeast of Matagami, Québec. The ATI permit was issued on February 16, 2026, and is valid for 3 years.

...keep reeding on newsfilecorp.com

...
FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer

Basel, 20 February 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States (U.S.) Food and Drug Administration (FDA) has accepted the company's New Drug Application for giredestrant, an investigational oral therapy,  in combination with everolimus for the treatment of adult patients with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated locally advanced or metastatic breast cancer following recurrence or progression on a prior endocrine-based regimen. The FDA is expected to make a decision on the approval by 18 December 2026. Giredestrant plus everolimus could be the first and only oral selective oestrogen receptor degrader (SERD) combination approved in the post-cyclin-dependent kinase (CDK)4/6 inhibitor setting.

...keep reeding on globenewswire.com

...
dsm-firmenich publishes 2025 Integrated Annual Report

Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrated Annual Report (IAR) for 2025, a year during which the company advanced its innovation-led growth agenda, sharpened its strategic profile, and delivered a good performance. The 2025 IAR offers a comprehensive overview of dsm-firmenich's financial and non-financial progress during the past year.

...keep reeding on globenewswire.com

...
Apollo Provides $1 Billion Hybrid Capital Solution to Aldar

Transaction marks Apollo's fifth investment in Aldar and the region's largest corporate hybrid private placement  Builds on Apollo's long-term strategic partnership with Aldar, with total transactions totalling approximately $2.9 billion to date Investment to support Aldar's transformational growth plans and capital structure optimization NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds have invested $1 billion in subordinated hybrid notes issued by Aldar Properties PJSC (“Aldar”), a leading UAE based real estate developer and investment manager. The investment builds on Apollo's long-term strategic partnership with Aldar and represents Apollo's fifth investment in Aldar since 2022, bringing aggregate commitments to $2.9 billion to date.

...keep reeding on globenewswire.com

...
Virtus Newfleet Multi-Sector Bond ETF Q4 2025 Commentary

Virtus Newfleet Multi-Sector Bond ETF Q4 2025 Commentary

...keep reeding on seekingalpha.com

...
Independent Proxy Advisory Firms Recommend HIVE Shareholders Vote "FOR" All Resolutions

Your vote is important – Vote well in advance of the proxy voting deadline: 11:00 a.m. (Pacific time) on March 3, 2026.

...keep reeding on newsfilecorp.com

...
Beyond SoFi Stock: This Other Cash-Gushing Bank Stock Is Worth Your Money

As SoFi Technologies continues to grow its user base at a healthy clip, the stock remains positioned to keep rising on increased earnings. Alongside this growth-focused name is another bank stock that could pull off a similar extended rally: Citigroup.

...keep reeding on fool.com

...
Alarm.com Holdings, Inc. (ALRM) Q4 2025 Earnings Call Transcript

Alarm.com Holdings, Inc. (ALRM) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Prediction: This Will Be Nvidia's Stock Price by the End of 2026

Nvidia has several growth catalysts emerging in 2026. Wall Street analysts are bullish on Nvidia's future.

...keep reeding on fool.com

...
Mineral Resources Limited (MALRY) Q2 2026 Earnings Call Transcript

Mineral Resources Limited (MALRY) Q2 2026 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Megaport Limited (MGPPF) Q2 2026 Earnings Call Transcript

Megaport Limited (MGPPF) Q2 2026 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Three Silicon Valley engineers charged with stealing Google trade secrets and sending data to Iran

Three Silicon Valley engineers were indicted for allegedly sending trade secrets to Iran. Personal devices linked to the defendants were allegedly used to search for methods to delete communications.

...keep reeding on cnbc.com

...
'Canary in the coal mine': Blue Owl liquidity curbs fuel fears about private credit bubble

Blue Owl Capital permanently restricted withdrawals from one of its retail-focused debt funds. Market watchers warn Blue Owls move could be the canary in the coal mine.

...keep reeding on cnbc.com

...
Mowi ASA: Ex-dividend NOK 1.50 today

The shares in Mowi ASA will be traded ex-dividend of NOK 1.50 as from today 20 February 2026. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

...keep reeding on globenewswire.com

...
Perseus Mining Focused on Internal Growth; Will Keep Predictive Stake For Now

Perseus Mining's chief executive said the gold producer is focused on developing its own growth options after a failed bid for Predictive Discovery and has no current plans to sell its stake in the Africa-focused explorer.

...keep reeding on wsj.com

...
GLD: My Second-Largest Portfolio Position, On Path To Become My Largest Holding

SPDR Gold Shares ETF remains a buy, with long-term fundamentals intact despite recent price volatility. GLD has delivered nearly a 10-fold return since inception and currently holds over $174 billion in assets backed by 1,080 tonnes of gold. Recent retail weakness in physical gold sales is offset by robust ETF inflows and continued central bank gold buying.

...keep reeding on seekingalpha.com

...
AI Bust or a Once-in-a-Decade Buying Opportunity for This Software Stock?

AI is an opportunity, not a threat, for PTC's business model, and growth in its key metric is set to rebound in the near future. The stock's valuation hasn't been this cheap in a decade.

...keep reeding on fool.com

...
Cobram Estate Olives Limited (CBOAF) Q2 2026 Earnings Call Transcript

Cobram Estate Olives Limited (CBOAF) Q2 2026 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Savers Value Village, Inc. (SVV) Q4 2025 Earnings Call Transcript

Savers Value Village, Inc. (SVV) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Inseego Corp. (INSG) Q4 2025 Earnings Call Transcript

Inseego Corp. (INSG) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Amazon's cloud unit hit by at least two outages involving AI tools, FT says

Amazon's cloud unit has suffered at least two outages stemming from errors involving its own AI tools, the Financial Times reported on Friday, citing people familiar with the matter.

...keep reeding on reuters.com

...
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing

ORBIMED Advisors LLC reduced stake by 5,409,671 shares in Terns Pharmaceuticals; the estimated trade size is $125.01 million based on quarterly average price Quarter-end position value decreased by $30.20 million, reflecting both trading and share price movement Transaction represented 2.55% of fund's 13F reportable AUM Post-trade position: 2,153,300 shares, valued at $86.99 million Stake now makes up 1.78% of fund AUM, placing it outside the fund's top five holdings These 10 Stocks Could Mint the Next Wave of Millionaires ›

...keep reeding on fool.com

...
The CEO Magazine Launches The Collection: A New Editorial Platform Curating the World's Most Trusted Businesses

/PRNewswire/ -- The CEO Magazine has announced the launch of The Collection, a new editorial platform designed to curate and showcase exceptional businesses,

...keep reeding on prnewswire.com

...
Altus Group Limited (AIF:CA) Q4 2025 Earnings Call Transcript

Altus Group Limited (AIF:CA) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Select Water Solutions Announces Pricing of Public Offering of Common Stock

GAINESVILLE, Texas, Feb. 19, 2026 /PRNewswire/ -- Select Water Solutions, Inc. (NYSE: WTTR) ("Select," the "Company," "we," "our" or "us"), today announced the pricing of an underwritten public offering of 13,725,491 shares of its Class A common stock, par value $0.01 per share ("Class A Common Stock"), at a price to the public of $12.75 per share, pursuant to an effective shelf registration statement on Form S-3 (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "SEC"). The Company intends to use the net proceeds it receives from the offering for general corporate purposes, including water infrastructure growth capital projects, potential acquisitions or debt repayment under the Company's sustainability-linked credit facility.

...keep reeding on prnewswire.com

...
Innovative Industrial: Forget The 16.5% Yield, Get The 9.7%-Yielding Preferreds

Innovative Industrial Properties is rated Hold due to regulatory headwinds, a possible dividend cut, and a lack of stock momentum despite a 16.5% yield. IIPR trades at 0.7x book value, but AFFO per share no longer covers the dividend; a cut could occur as soon as the next earnings report. Regulatory uncertainty around cannabis rescheduling and ongoing tenant defaults keep IIPR's common shares range-bound and risk profile elevated.

...keep reeding on seekingalpha.com

...
Nebius Gave Amazing News to Nvidia and CoreWeave Shareholders

Nebius continues to see massive demand for AI infrastructure.

...keep reeding on fool.com

...
Gold and Silver Analysis: US-Iran Tensions and Gold-to-Silver Ratio Signal Upside

Gold stays above $5,000 on rising safe-haven demand from US-Iran tensions, while ratio dynamics, strong technical consolidation, and a base in silver keep the broader bullish outlook intact.

...keep reeding on fxempire.com

...
Dow Jones & Nasdaq 100 Steady as Oil Hits 7-Month High

US futures steady in Asian markets as Iran tensions lift oil to 7-month highs, while Fed rate cut bets and key US data drive Dow Jones and Nasdaq 100 outlook.

...keep reeding on fxempire.com

...
Air France-KLM CEO: Europe not protecting our industry

Benjamin Smith, CEO of Air France-KLM, discusses cost pressures, fleet delays, and Europe's competition challenges.

...keep reeding on youtube.com

...
RSBT ETF: It's A Directional Bet, Not A Diversification Vehicle

The Return Stacked Bonds & Managed Futures ETF has delivered a 12.25% year-over-year price return after shedding value during 2022/23's inflation de-anchoring – the vehicle remains cyclical and macro-linked. RSBT splits capital between AGG ETF and managed futures, relying on leading trend-following strategies. However, I think relative value or discretionary would've provided better diversification. Despite showing soft intra-asset correlations, covariance can spike during extreme market environments. Moreover, true portfolio convexity or downside protection has yet to surface.

...keep reeding on seekingalpha.com

...
LegalZoom.com, Inc. (LZ) Q4 2025 Earnings Call Transcript

LegalZoom.com, Inc. (LZ) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com

...
Best Payroll Software UK (Feb 2026): QuickBooks Named Best Payroll Solution for UK Small Businesses by Better Business Advice

/PRNewswire/ -- Better Business Advice has recognised Intuit's QuickBooks Payroll as one of the best payroll software solutions available to UK businesses. The

...keep reeding on prnewswire.com

...
Back Near $1,000, Is Costco Stock a Buy Now?

The membership-based wholesale retailer's recent comparable sales trends remain steady. Digitally enabled sales growth trends are particularly encouraging, supporting the long-term story.

...keep reeding on fool.com

...
Newmont Corporation (NEM) Q4 2025 Earnings Call Transcript

Newmont Corporation (NEM) Q4 2025 Earnings Call Transcript

...keep reeding on seekingalpha.com